Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Patent CN114426508A reveals a novel one-pot synthesis for beta-carotene intermediates. Achieve >90% yield with simplified purification and reduced operational costs.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN104031063A reveals novel cyanation route for high-purity quinolone intermediates enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN106282135A details a robust RrQR enzyme process for (R)-3-quinuclidinol, offering superior stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN107698523A offers high-yield Gefitinib preparation with reduced pollution and cost advantages for supply chain stability.
Patent CN113651864A reveals a safer synthesis route for Diquafosol Tetrasodium using inorganic ammonia, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
This patent details a novel biocatalytic route for sitagliptin intermediates offering high purity and yield. It enables significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Advanced catalytic hydrogenation process for anisidine production offering high purity, reduced waste, and scalable industrial solutions for global supply chains.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Discover a green synthesis method for Cefodizime Sodium replacing toxic catalysts. Achieve >99.7% purity and significant cost reduction in pharmaceutical manufacturing.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.
Novel 4-step route avoids hazardous LiAlH4 reduction. Offers cost reduction in pharma intermediate manufacturing with high purity and scalability.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Novel 3-step synthesis via nitration-reduction-bromination ensures >98% purity. Cost-effective route for reliable pharmaceutical intermediate supply chain.
Novel rhodium-catalyzed route ensures high purity intermediate for Suvorexant. Reduces toxicity and simplifies supply chain for global pharmaceutical manufacturing partners.